/CD10
+ B-lineage precursors in the bone marrow. In line with this assumption, Southern blot studies have shown that Ͼ95% of precursor-B-ALL have IGH gene rearrangements, that most of them contain immunoglobulin (Ig) kappa light chain gene rearrangements (60%), and that even 20% of precursor-B-ALL have Ig lambda light chain gene rearrangements. [5] [6] [7] [8] Newly diagnosed childhood precursor-B-ALL are frequently oligoclonal and contain multiple IGH gene rearrangements (30% to 40% of cases). 6, 9 These multiple IGH gene rearrangements are caused by continuing rearrangement processes (eg continuing V H to D H -J H joining), as well as secondary rearrangements (eg D H -J H replacements, V H replacements), which result in one or more subclones. [9] [10] [11] [12] [13] PCR studies in precursor-B-ALL employing V H -J H primer sets showed generally lower frequencies of IGH gene rearrangements as compared to Southern blot analyses. [14] [15] [16] [17] [18] This was assumed to be caused in large by the presence of incomplete D H -J H rearrangements. Two limited studies indeed revealed clonal D H -J H rearrangements in a total of 14 out of 19 precursor-B-ALL patients (74%) with biallelic rearrangements in Southern blotting, but no clonal V H -(D H -)J H rearrangements by PCR. 16, 19 However, no systematic investigations have been published on the frequency and types of clonal D H -J H rearrangements in a random group of precursor-B-ALL patients. Most published data on D H -J H rearrangements in precursor-B-ALL have in fact been obtained indirectly from the sequences of clonal V H -(D H -)J H joinings. 15, 20 This limited information about D H -J H rearrangements is partly caused by the fact that the complete sequence of the D H region was published only recently. 21, 22 In this study we aimed at a thorough analysis of D H -J H rearrangements in childhood precursor-B-ALL patients using combined Southern blot and heteroduplex PCR analyses. We first determined the precise frequency of clonal D H -J H rearrangements in a non-selected series of 97 children with precursor-B-ALL. Secondly, we correlated the presence of clonal incomplete D H -J H joinings with several immunobiological and clinical features of these patients. Finally, we critically assessed the potential application of clonal D H -J H rearrangements as PCR targets for monitoring of minimal residual disease (MRD).
Materials and methods

Patients
Peripheral blood (PB) or bone marrow (BM) samples from 97 precursor-B-ALL patients were obtained at initial diagnosis. The age distribution ranged from 3 months to 190 months. Four children (4%) were infants (age Ͻ1 year). The diagnosis Leukemia of precursor-B-ALL was made according to FAB and standard immunophenotypic criteria. [23] [24] [25] Immunological marker analysis of the precursor-B-ALL revealed that four (4%) were pro-B-ALL, 64 (66%) were common ALL, and 29 (30%) were pre-B-ALL. The status of chromosome 14 was based on routine cytogenetics as available in the Dutch Childhood Leukemia Study Group (DCLSG) database. Most patients (91 out of 97) were treated according to the DCLSG ALL-8 treatment protocols. 26 
Southern blot analysis
Mononuclear cells (MNC) were separated from PB or BM samples by Ficoll-Paque centrifugation (density 1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden). DNA was isolated from MNC, digested, and blotted to nylon membranes as described previously. 27 IGH gene rearrangements were studied by use of the 32 P-labeled IGHJ6 probe (DAKO, Carpinteria, CA, USA) in BglII and BamHI/HindIII digests. 28 In 88 patients the configuration of the T cell receptor (TCR) genes was established as previously reported. 29 
PCR amplification and heteroduplex analysis of PCR products
PCR was essentially performed as described previously. 30, 31 In each 50-l PCR reaction 50 ng DNA sample, 6.3 pmol of the 5Ј and 3Ј oligonucleotide primers, and 0.5 U AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA, USA) were used. The sequences of the 12 oligonucleotides used for amplification of complete V H -J H and incomplete D H -J H gene rearrangements ( Figure 1 ) were published before. 32, 33 The V H 4/6 primer recognizes both V H 4 gene segments and the single member V H 6 family (V H 6-1 gene segment). In addition, 91 patients were tested with the V H 6-J H primer combination to identify patients with V H 6-1 gene rearrangements. PCR conditions were pre-activation of the enzyme for 10 min at 94°C, followed by 35 cycles of 45 s at 92°C, 90 s at 60°C, and 2 min at 72°C using a Perkin-Elmer 480 thermal cycler
Figure 1
Schematic diagrams of V H -D H -J H and D H -J H junctional regions with primers for PCR analysis. The sequence, approximate position and orientation (5Ј → 3Ј) of the V H family-specific framework 1 (V H -FR1) and D H family-specific primers, as well as of the J H consensus primer are indicated. 32, 33 (Applied Biosystems). After the last cycle an additional extension step of 10 min at 72°C was performed. Appropriate positive and negative controls were included in all experiments. 31 In order to distinguish between polyclonal and monoclonal rearrangements, heteroduplex analysis of the obtained PCR products was performed as described previously. 34 In short, the PCR products were denatured at 94°C for 5 min to obtain single-stranded PCR products. Subsequently the singlestranded products were cooled to 4°C for 60 min to induce random renaturation (duplex formation). 34 In case of monoclonal gene rearrangements, homoduplexes are formed (identical junctional regions), whereas heteroduplexes are found in case of polyclonal gene rearrangements (heterogeneous junctional regions). The duplexes obtained were immediately loaded on 6% non-denaturing polyacrylamide gels in 0.5 × tris-borate-EDTA (TBE) buffer, run at room temperature, and visualized by ethidium bromide staining in order to discriminate between the presence of rapidly migrating homoduplex bands or slowly migrating heteroduplexes smears; the remaining single-strand molecules migrate very slowly ( Figure 2 ).
Sequence analysis of IGH gene rearrangements
Sequence analysis concerned both V H -J H and D H -J H gene rearrangements in all patients in whom at least one clonal incomplete D H -J H rearrangement was found by heteroduplex analysis. When heteroduplex PCR analysis revealed more than two clonal bands, ie either two homoduplexes, or an additional upper band resulting from extension to downstream J H segments, or a D H 7-27-J H 1 germline band accompanying a D H 7-27-J H rearrangement, homoduplexes were excised from the polyacrylamide gel and eluted as described before. 33 The eluted PCR products were either directly sequenced or subjected to second step PCR with the same primer pair to
Figure 2
Heteroduplex PCR analysis in 17 precursor-B-ALL patients to distinguish between polyclonal and monoclonal IGH gene rearrangements. Using the V H 3-J H primer combination clonal homoduplexes were found in the majority ( Event-free survival (EFS) was defined as the time from diagnosis to induction failure, relapse, death in remission, or the occurrence of a second tumor. For patients event-free alive at the latest follow-up time point (censored observations) EFS was calculated till this latest follow-up. Patients who did not achieve remission, were included in the analysis and considered as treatment failures with EFS of 0 days. Survival curves and standard errors were calculated according to the Kaplan-Meier method.
Results
Southern blot configuration of IGH genes
Clonal IGH gene rearrangements were demonstrated by Southern blot analysis in 94 out of 97 precursor-B-ALL patients (97%). In the other three patients monoallelic (two cases) or biallelic (one patient) IGH deletions were assumed based on the percentages of leukemic blasts and the relative density of rearranged and germline bands. Biallelic rearrangements were found in 85 out of 97 patients (88%), in eight patients the second IGH allele was deleted (8%), and only in a single patient the second allele was in germline configuration. In 13 patients three, and in two patients four IGH gene rearrangements with Southern blot bands of identical density were found suggesting trisomy and tetrasomy 14, respectively. In 30 out of 97 precursor-B-ALL patients (31%) the presence of rearranged bands of different densities or additional weak bands suggested oligoclonality.
Complete V H -(D H -)J H and incomplete D H -J H rearrangements
Detailed heteroduplex PCR analysis of the IGH locus in the 97 precursor-B-ALL patients was based on 12 primer combinations ( Figure 1 ) theoretically covering the majority of complete V H -(D H -)J H joinings and all incomplete D H -J H rearrangements. With this approach at least one clonal PCR product was demonstrated in all 94 patients with Southern blot detectable IGH gene rearrangements. However, in only 43 patients Leukemia (46%) the number of clonal PCR products exactly matched the number of Southern blot bands. In 45 patients (48%) the number of clonal homoduplexes was lower as compared to the number of rearrangements in Southern blot analysis. This concerned 29 patients with monoclonal IGH rearrangements and 16 patients with oligoclonal IGH gene rearrangements. In contrast, in six patients (6%) the number of clonal homoduplexes exceeded the number of rearrangements in Southern blot analysis. Five of these six patients were considered to have monoclonal IGH gene rearrangements based on Southern blotting, which indicates that the additional clonal PCR products most probably represented minor subclones, not detectable by Southern blotting.
Clonal complete V H -(D H -)J H rearrangements were found in 89 patients (92%) as exemplified in Figure 2 , while incomplete D H -J H rearrangements were demonstrated in only 21 patients (22%) (exemplified in Figure 3 for the most frequently observed D H -J H couplings). In only five patients (5%), the incomplete D H -J H joinings were the sole IGH rearrangements. Hence, 16 patients had both complete and incomplete IGH gene rearrangements. 
Usage of D H gene segments in incomplete D H -J H gene rearrangements
Usage of J H gene segments in incomplete D H -J H gene rearrangements
The frequencies of different J H gene segments in the 31 D H -J H gene rearrangements are summarized in Table 2 . Remarkably, the J H 6 gene segment was found in more than 60% of the joinings, followed by J H 4 and J H 5, each occurring in 16% of cases. The J H 3 gene segment was found in two D H -J H gene rearrangements (7%), while the two most upstream J H 1 and J H 2 genes were not utilized in the 31 analyzed incomplete D H -J H joinings. Table 3 ). In another four of the 10 oligoclonal patients the V H -(D H )-J H and D H -J H sequences were not related, which might be caused by secondary rearrangements, which replaced pre-existing rearrangements. In the last two patients, the oligoclonality was based on the presence of two rearranged bands of different density on Southern blot analysis; in one of the two patients the identified sequences were not related and in the other patient the type of relation could not be established because one of the IGH rearrangements remained unidentified.
Sequences of complete V H -(D H )-J H gene rearrangements in precursor-B-ALL patients with incomplete D H -J H gene rearrangements
IGH gene configuration and chromosome 14 status in precursor-B-ALL patients with incomplete D H -J H gene rearrangements as compared to D H -J H -negative patients
Based on Southern blot analysis, 10 of the 21 precursor-B-ALL patients with incomplete D H -J H rearrangements were classified as oligoclonal (48%), which is markedly higher than in the D H -J H -negative group (19 of 76 patients, 25%). In addition, five D H -J H -positive patients (24%) were assumed to have trisomy 14 and one patient probably had tetrasomy 14, based on the presence of three or four rearranged bands of equal density on Southern blot analysis. Although these frequencies are higher than in the D H -J H -negative group, the differences did not reach statistical significance. However, patients with monoclonal biallelic IGH gene rearrangements were significantly underrepresented in the D H -J H -positive group (24% vs 59% in the D H -J H -negative group, P Ͻ 0.01). biallelic IGH rearrangements, which might indicate that the additional copies of chromosome 14 in these cases characterized minor subclones. In the remaining seven patients the Southern blot-based IGH configuration was oligoclonal. Interestingly, two of these oligoclonal cases were classified as biclonal based on the presence of two rearranged bands of different densities in Southern blotting. In both patients two clonal V H -(D H )-J H rearrangements were demonstrated by heteroduplex PCR analysis. This suggests that trisomy 14 in these patients resulted from duplication of a chromosome 14 with an existing rearranged IGH gene. In another two oligoclonal patients and in at least three monoclonal cases with trisomy 14, the sequence analysis revealed identical D H -J H stems in at least two of the rearrangements. Apparently, in these patients the chromosome duplication developed after the incomplete D H -J H recombination, but before ongoing V H to D H -J H joining. Finally, in two oligoclonal cases the sequences of IGH rearrangements were completely unrelated, which is indicative of duplication of chromosome 14 as a very early event preceding recombination in the IGH locus.
TCR gene configuration in precursor-B-ALL patients with incomplete D H -J H gene rearrangements as compared to D H -J H -negative patients
Cross-lineage TCR gene rearrangements were found in 66 of 69 (96%) D H -J H -negative patients and in 17 of 19 (90%) of D H -J H -positive patients. However, detailed TCR gene rearrangements patterns significantly differed between the two groups. TCR gamma (TCRG) gene rearrangements were observed in only two D H -J H -positive patients (11%) as compared to 49 D H -J H -negative patients (71%, P Ͻ 0.01). Although the recombination in TCR alpha/delta locus occurred with similar frequencies in both groups (approximately 90% of patients), it rarely concerned TCR delta (TCRD) deletions in the D H -J H -positive group: monoallelic deletions in two patients (11%) and no biallelic deletions. This was in striking contrast (P Ͻ 0.01) to the D H -J H -negative group, where monoallelic and biallelic deletions were found in 19 (28%) and 21 patients (30%), respectively. Finally, TCR beta (TCRB) gene rearrangements were slightly less prevalent in the D H -J H -positive group (4/19 patients, 21% vs 26/69 D H -J H -negative patients, 38%; not significant) and exclusively concerned monoallelic incomplete D␤-J␤2 rearrangements. In striking contrast, TCRB gene rearrangements were biallelic in 50% (13/26) of D H -J H -negative patients, while complete V␤-J␤2 joinings were found in 69% (18/26) of patients.
Clinical and laboratory characteristics of D H -J Hpositive patients
Clinical and laboratory characteristics of D H -J H -positive vs D H -J H -negative patients are summarized in Table 4 . The two patient groups showed similar age and sex distribution. The only significant clinical difference concerned the frequency of infant ALL, which comprised 14% (three cases) of D H -J H -positive precursor-B-ALL as compared to 1% (one case) of D H -J H -negative patients (P Ͻ 0.05). However, owing to the low frequency of infant ALL this difference should be interpreted with caution. Both D H -J H -positive and D H -J H -negative groups showed similar distribution of precursor-B immunophenotypes. Strikingly, cytogenetic and DNA index analyses demonstrated a statistically significant overrepresentation of patients with hyperdiploidy Ͼ50 chromosomes and increased DNA index (у1.16) in the D H -J H -positive group (40-50% as compared to 20% in D H -J H -negative patients; P Ͻ 0.01). The stratification into the three treatment risk groups was comparable between the D H -J H -positive and the D H -J H -negative patients. Both groups showed similar early treatment response to prednisone. Finally, the presence of incomplete D H -J H rearrangements influenced neither the event-free survival nor the overall survival (Figure 4 ).
Discussion
The frequency and molecular characteristics of incomplete D H -J H gene rearrangements were investigated in precursor-B-ALL patients. 15, 20, 37, 38 In contrast, the segments of the 39, 40 This finding together with the frequent lack of N-nucleotide insertions in D H -J H junctions supports the hypothesis that a significant proportion of childhood precursor-B-ALL originates in utero. 15, 41, 42 Concerning the J H gene usage, we observed a striking predominance of the most downstream J H 6 segment, which was found in 61% of clonal D H -J H gene rearrangements. This is twice as much as reported for HCDR3 in normal and malignant B-lineage cells (Table 2) . 15, 37, 43 This observation together with the finding of predominant usage of D H genes from the more upstream part of the D H region (78%) suggests that most D H -J H gene rearrangements in precursor-B-ALL actually represent secondary recombinations deleting pre-existing D H -J H joinings.
The patients with incomplete D H -J H gene rearrangements were frequently characterized by hyperdiploid karyotype (52%) with additional copies of chromosome 14 (56%) and/or by IGH oligoclonality (52%). Combined cytogenetic, Southern blot and PCR data revealed a complex relationship between the hyperdiploidy 14, IGH gene configuration, and subclone formation. In our series, additional copies of chromosome 14 were found in 28% of precursor-B-ALL patients, which is in line with previously published cytogenetic data. 44 Sequence analysis showed that this type of chromosomal aberration might occur before IGH gene rearrangements, but more frequently parallels ongoing V H to D H -J H joining or might even affect cells with an end-stage (stable) IGH configuration. Although it is difficult to explain how the presence of D H -J H rearrangements is related to trisomy 14, it suggests that having extra copies of chromosome 14 freezes the ALL cells in a more immature immunogenotypic stage. In this context it was striking to observe that hyperdiploidy of chromosome 14 was inversely associated with TCRD gene deletions, which are regarded as a more mature immunogenotypic feature. The association between D H -J H gene rearrangements and IGH oligoclonality is obviously explained by the presence of ongoing and secondary recombination events. The presence of incomplete D H -J H joinings was also significantly associated with a less mature immunogenotype as reflected by overrepresentation of the most downstream V H 6-1 gene segment, the virtual absence of monoallelic TCRD deletions, the full absence of biallelic TCRD deletions, low frequency of TCRG gene rearrangements, the absence of complete V␤-J␤ rearrangements, and the absence of biallelic TCRB rearrangements. However, these distinct immature immunogenotypic features of precursor-B-ALL with clonal incomplete IGH gene rearrangements were not associated with more aggressive disease (Figure 4) . The frequency of high-risk features at diagnosis, early treatment response, as well as long-term eventfree survival, did not significantly differ between D H -J H -negative and D H -J H -positive patients (Table 4) . Thus, the presence of clonal incomplete IGH gene rearrangements has no direct clinical implications, although associated with immunobiological features of immature B cell differentiation stages.
In this study, we demonstrated that clonal V H -(D H -)J H gene rearrangements can be easily identified in the vast majority of precursor-B-ALL patients and can serve as PCR targets for MRD monitoring (Figure 2 ). However, in almost half of the cases the number of clonal PCR products was lower than the number of rearrangements in Southern blot analysis, including 29 monoclonal cases with an undetectable second allele. Our PCR analyses correctly assigned 105 alleles in 67 patients with monoclonal biallelic IGH rearrangements, which gives an overall sensitivity of 78%. Although chromosome translo-Leukemia cations involving the IGH gene might occur, the recombinations undetectable by PCR most probably represent unidentified V H -(D H -)J H gene rearrangements. Particularly the newly discovered V H pseudogenes might be involved in these rearrangements since many of them contain proper recombination signal sequences, while they frequently lack framework one sequences, which are recognized by the currently used V H family-specific primers. 22 Since the types of preferential D H -J H gene rearrangements have now been identified, it would be relatively easy to screen precursor-B-ALL patients for the presence of incomplete IGH gene rearrangements and apply them as PCR targets for MRD monitoring, particularly in patients without detectable clonal complete V H -(D H -)J H joinings. Three primer combinations (D H 2, D H 3, and D H 7 in combination with a J H consensus primer) can identify 89% of incomplete D H -J H rearrangements in precursor-B-ALL ( Figure 3 ) and result in clonal PCR products in all patients without V H -J H rearrangements. However, it should be noted that incomplete D H -J H gene rearrangements are associated with IGH oligoclonality in at least 52% of patients. Moreover, in one third of patients with clonal D H -J H gene rearrangements we found evidence for continuing V H to D H -J H recombination already at diagnosis (Table 3) . IGHbased MRD detection in such patients is still possible and could rely on so-called common D H -J H stems, which are preserved in different V H -(D H -)J H joinings. Such an approach is feasible with the currently used real-time quantitative PCR approaches for MRD detection based on TaqMan technology. [45] [46] [47] [48] In some cases this strategy might be hampered by the lack of N-nucleotide insertions, which concerns 20-30% of IGH gene rearrangements in precursor-B-ALL. 15 D H -J H stems in rearrangements involving the most downstream J H 6 gene segment (ie 60% of all incomplete joinings) could be perceived as 'end-stage' rearrangements, which probably are stable throughout the disease course. This is not the case with the D H -J H rearrangements involving upstream J H gene segments, which might be subjected to D H -J H replacements. We found evidence for such secondary (replacement) rearrangement patterns in 20% of patients at diagnosis. If they occur during the disease course, they might lead to false-negative MRD results. In conclusion, incomplete D H -J H gene rearrangements can be perceived as a supplementary MRD-PCR target, particularly useful for patients who do not have other leukemia-specific targets, such as complete V H -(D H -)J H joinings, Ig kappa deleting element (Kde) rearrangements, and cross-lineage TCRG and TCRD gene rearrangements or in whom the other MRD-PCR targets are not suitable because of insufficient sensitivity.
